---
format: "aidr-story-markdown/v1"
id: "10cc281230f2c365dda6a05669599f702c990c5fb5d35e8b57776afcd20ec870"
canonical_url: "https://aidr.today/10cc2812?lang=en"
title: "Geodesic's NovaAtom-Lite Outperforms AlphaFold 3 on Drug Discovery Benchmark"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-11-10T18:22:06.000Z"
category: "Models"
topics: ["inference"]
source_urls: ["https://marketbrief.now/ai/geodesics-novaatom-lite-outperforms-alphafold-3-on-drug-discovery-benchm-b5c2982c","https://huggingnews.com/ai/geodesics-novaatom-lite-outperforms-alphafold-3-on-drug-discovery-benchm-b5c2982c"]
summary: "Geodesic launched NovaAtom-Lite, an all-atom structure prediction model for drug discovery. NovaAtom-Lite achieved a success rate of 79.07% across 172 samples on the FoldBench antibody-antigen structure prediction benchmark. The model surpassed IsoDDE with 75.58% and AlphaFold 3 with 47.90% on the same benchmark. NovaAtom-Lite is available through the NovaDDE platform and the Geodesic API."
---

# Geodesic's NovaAtom\-Lite Outperforms AlphaFold 3 on Drug Discovery Benchmark

> [Open the canonical story](<https://aidr.today/10cc2812?lang=en>)

**Published:** 2026-11-10T18:22:06.000Z
**Category:** Models
**Topics:** inference

## Summary

Geodesic launched NovaAtom\-Lite, an all\-atom structure prediction model for drug discovery\. NovaAtom\-Lite achieved a success rate of 79\.07% across 172 samples on the FoldBench antibody\-antigen structure prediction benchmark\. The model surpassed IsoDDE with 75\.58% and AlphaFold 3 with 47\.90% on the same benchmark\. NovaAtom\-Lite is available through the NovaDDE platform and the Geodesic API\.

## Sources

- [Story source](<https://marketbrief.now/ai/geodesics-novaatom-lite-outperforms-alphafold-3-on-drug-discovery-benchm-b5c2982c>)
- [Story source](<https://huggingnews.com/ai/geodesics-novaatom-lite-outperforms-alphafold-3-on-drug-discovery-benchm-b5c2982c>)